lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1 [Retraction]
Authors Qu Y, Liu J
Received 8 December 2020
Accepted for publication 8 December 2020
Published 11 December 2020 Volume 2020:13 Pages 12737—12738
Qu Y, Liu J. Onco Targets Ther. 2020;13:8359–8370.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article.
The journal was notified of potential image duplication in:
● Figure 3A – panel EC109 si-MAFG-AS1#2 and Figure 3C – panel EC109 si-NC, which appear to be duplicates of each other.
● Figure 3C – panel EC1 si-MAFG-AS1#2 and Figure 3G – panel EC1 GV-NC, which appear to be duplicates of each other.
The authors did not provide the necessary raw data for their study and the editor determined the findings of the study were no longer valid and requested for the paper to be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]